David Shook - Chief Medical Officer, Head of Research & Development at Nkarta, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer, Head of Research & Development
Stock Symbol
NKTX on Nasdaq
All Insider Reports
All Insider Reports

David Shook - trading volume in the past year for Nkarta, Inc.

Holdings reported by David Shook for Nkarta, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 191K $420K $2.20 Jan 15, 2025 Direct
Stock Option (right to buy) 118K Jan 3, 2025 Direct Common Stock

Transactions reported by David Shook for Nkarta, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.